Syringocystadenocarcinoma papilliferum (SCACP) is a rare cutaneous adnexal neoplasm. To the best of our knowledge, fewer than 50 cases have been described in the literature. We describe the first reported case of an SCACP in an immunocompromised patient. We report the development of an SCACP over 3 months in a 77-year-old organ transplant recipient undergoing regular dermatological follow-up. The lesion was excised with clear margins with Mohs micrographic surgery. This lesion's rapid development and small size contrasts with the predominantly slow-growing, larger lesions described in immunocompetent patients. Lastly, this case further highlights the importance of close dermatological follow-up of immunosuppressed patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209998PMC
http://dx.doi.org/10.1159/000524821DOI Listing

Publication Analysis

Top Keywords

rapid development
8
syringocystadenocarcinoma papilliferum
8
transplant recipient
8
dermatological follow-up
8
development syringocystadenocarcinoma
4
papilliferum immunosuppressed
4
immunosuppressed liver
4
liver transplant
4
recipient syringocystadenocarcinoma
4
papilliferum scacp
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!